Weichert Dietmar, Gmeiner Peter
Department of Chemistry and Pharmacy, Medicinal Chemistry, Emil Fischer Center, Friedrich Alexander University, Schuhstraße 19, 91052 Erlangen, Germany.
ACS Chem Biol. 2015 Jun 19;10(6):1376-86. doi: 10.1021/acschembio.5b00070. Epub 2015 Apr 22.
Covalent modification of G protein-coupled receptors (GPCRs) by employing specific molecular probes has for decades provided a successful strategy to facilitate the elucidation of the structure and function of this pharmacologically important class of membrane proteins. The ligands typically comprise a pharmacophore that generates affinity for a given GPCR and contain a reactive functionality that may form a covalent bond with a suitably positioned amino acid residue. Covalent ligands have been successfully applied to circumvent poor affinity of compounds when stable labeling of receptor populations was required, and they have been used in the isolation, purification, and pharmacological characterization of specific subtypes of GPCRs. Recently, structural studies have demonstrated that covalent molecular probes are effective at stabilizing GPCRs to obtain X-ray crystal structures, thus providing valuable insights for the development of novel therapeutics. Herein, we review covalently binding molecular probes for class A GPCRs with a focus on ligands comprising cross-linking groups that do not require photoactivation and further highlight their significant and diverse applications.
几十年来,通过使用特定分子探针共价修饰G蛋白偶联受体(GPCR),为阐明这类在药理学上具有重要意义的膜蛋白的结构和功能提供了一种成功的策略。这些配体通常包含一个药效基团,它对给定的GPCR产生亲和力,并含有一个可与适当位置的氨基酸残基形成共价键的反应性功能团。当需要对受体群体进行稳定标记时,共价配体已成功用于克服化合物亲和力差的问题,并且它们已被用于GPCR特定亚型的分离、纯化和药理学表征。最近,结构研究表明,共价分子探针在稳定GPCR以获得X射线晶体结构方面是有效的,从而为新型治疗药物的开发提供了有价值的见解。在此,我们综述了用于A类GPCR的共价结合分子探针,重点关注包含不需要光活化的交联基团的配体,并进一步强调它们的重要和多样的应用。